文献速递慢病防控与筛查卫生政策与健康促进

现代方法反思:存在永恒时间偏倚时的试验模拟——基于观察性数据评估老年肺癌手术获益

Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data.
PubMed 文献 · Int J Epidemiol · 2020-01-01

该教程逐步介绍在存在永恒时间偏倚时开展模拟试验的设计与分析,并提供R与Stata代码。以70–89岁早期肺癌患者观察性数据为例,朴素Kaplan-Meier分析高估手术1年生存获益22%,克隆数据忽略信息性删失时高估17%,加权分析后仍显示获益但差异缩小至11%。方法透明且易于非专业人员理解。

要点

  • 模拟试验需按五步:指定目标试验与纳入标准、克隆患者、定义删失与生存时间、估计权重、分析数据。
  • 直接Kaplan-Meier分析因治疗组间特征严重不平衡而高估手术1年生存获益22%。
  • 加权分析仍显示手术对老年早期肺癌患者1年生存有获益,但差异缩小至11%。

核心结论

  • 在存在永恒时间偏倚时,模拟试验框架结合权重分析可减少混杂与信息性删失偏倚,获得更真实的因果效应估计。

研究设计与样本

  • 方法学教程,以70–89岁早期肺癌患者观察性数据为例,逐步展示模拟试验的设计与分析并提供R与Stata代码。

主要发现

  • 朴素Kaplan-Meier分析初始队列严重高估手术对1年生存的获益,差异为22%。
  • 克隆数据集忽略信息性删失的生存分析高估手术获益,差异为17%。
  • 加权分析充分消除协变量不平衡后,仍显示手术对1年生存有获益,差异为11%。

关键数值与推荐

  • 模拟试验步骤包括:指定目标试验与纳入标准、克隆患者、定义删失与生存时间、估计权重以处理设计引入的信息性删失、分析数据。

临床怎么用

  • 可利用教程提供的R与Stata代码,在观察性数据中开展模拟试验分析,以减少永恒时间偏倚和混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acquiring real-world evidence is crucial to support health policy, but observational studies are prone to serious biases. An approach was recently proposed to overcome confounding and immortal-time biases within the emulated trial framework. This tutorial provides a step-by-step description of the design and analysis of emulated trials, as well as R and Stata code, to facilitate its use in practice. The steps consist in: (i) specifying the target trial and inclusion criteria; (ii) cloning patients; (iii) defining censoring and survival times; (iv) estimating the weights to account for informative censoring introduced by design; and (v) analysing these data. These steps are illustrated with observational data to assess the benefit of surgery among 70-89-year-old patients diagnosed with early-stage lung cancer. Because of the severe unbalance of the patient characteristics between treatment arms (surgery yes/no), a naïve Kaplan-Meier survival analysis of the initial cohort severely overestimated the benefit of surgery on 1-year survival (22% difference), as did a survival analysis of the cloned dataset when informative censoring was ignored (17% difference). By contrast, the estimated weights adequately removed the covariate imbalance. The weighted analysis still showed evidence of a benefit, though smaller (11% difference), of surgery among older lung cancer patients on 1-year survival. Complementing the CERBOT tool, this tutorial explains how to proceed to conduct emulated trials using observational data in the presence of immortal-time bias. The strength of this approach is its transparency and its principles that are easily understandable by non-specialists.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Maringe C, Benitez Majano S, Exarchakou A, et al. Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data. Int J Epidemiol. 2020. PMID: 32386426. doi:10.1093/ije/dyaa057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。